Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer

NCT01433172 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Adenocarcinoma

Interventions

BIOLOGICAL: Phase I - GM.CD40L.CCL21 Vaccinations
BIOLOGICAL: Phase II - GM.CD40L cells Vaccinations
BIOLOGICAL: Phase II - GM.CD40L.CCL21 Vaccinations

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]